Wearables in Clinical Trials: Opportunities and Challenges

April 1

What You Missed at CES 2019

March 18

Wearables & The Early Warning System for Personal Health

December 6

Heart Rate Variability features: can we use SDNN instead of rMSSD?

November 10

What are biometric parameters and why do they matter?

October 17

Valencell, Inc. Attends CES 2013 and CEO Dr. Steven LeBoeuf Talks about PerformTek Technology

by Team Valencell | Mar 19, 2013 | News

attendsCES2013_video March 19, 2013 — Valencell’s Co-Founder & CEO Dr. Steven LeBoeuf spoke about his company’s sensor technology at the 2013 Consumer Electronics Show. Read More

Facebook
Twitter
LinkedIn

Wearables in Clinical Trials: Opportunities and Challenges

What You Missed at CES 2019

Wearables & The Early Warning System for Personal Health

Heart Rate Variability features: can we use SDNN instead of rMSSD?

What are biometric parameters and why do they matter?

Valencell, Inc. Attends CES 2013 and CEO Dr. Steven LeBoeuf Talks about PerformTek Technology

Categories

Recent Posts

Interested in more info?